Back to Search
Start Over
General principles and pharmacology of biologics in inflammatory bowel disease
- Source :
- Gastroenterology clinics of North America. 35(4)
- Publication Year :
- 2006
-
Abstract
- The pharmacology of each biologic agent is important regarding the dose required to achieve benefits, duration of therapeutic effect, and the induction of immunogenicity. Comprehension of the individual pharmacology, pharmacodynamics, and pharmacokinetics, in addition to the impact of concomitant immunomodulation on immunogenicity allows optimization of each biologic agent in the appropriate inductive or maintenance setting of IBD.
- Subjects :
- Anti-Inflammatory Agents
Pharmacology
Antibodies, Monoclonal, Humanized
complex mixtures
Inflammatory bowel disease
Polyethylene Glycols
Immunoglobulin Fab Fragments
Pharmacokinetics
Gastrointestinal Agents
Adalimumab
medicine
Humans
Certolizumab pegol
Biological Products
business.industry
Tumor Necrosis Factor-alpha
Immunogenicity
Natalizumab
Therapeutic effect
Gastroenterology
Antibodies, Monoclonal
medicine.disease
Inflammatory Bowel Diseases
Infliximab
Pharmacodynamics
Certolizumab Pegol
business
Cell Adhesion Molecules
medicine.drug
Subjects
Details
- ISSN :
- 08898553
- Volume :
- 35
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Gastroenterology clinics of North America
- Accession number :
- edsair.doi.dedup.....ad89b028d5e035fbc8bf54d3aff40e2f